Stay updated with breaking news from Greg gara. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Published: Jan 01, 2021 By Alex Keown ImmunityBio – Fabio M. Benedetti was named chief strategy officer of California-based ImmunityBio. Benedetti will oversee life-cycle management, pipeline and commercial strategy, including medical affairs. Following the completion of ImmunityBio’s proposed merger with NantKwest, Benedetti is expected to assume the role of chief strategy officer of the combined company. Benedetti most recently served as chief medical officer for Apollomics, Inc., where he led global clinical development programs including clinical strategy, clinical development, and regulatory affairs. He also previously served as Global CMO at Taiho Pharmaceutical Company, Ltd. and CMO for Taiho Oncology, Inc. Prior to Taiho, he held the positions of senior vice president of Clinical Oncology and CMO at Geron Corporation. He also held roles at Onyx Pharmaceuticals, Millennium Pharmaceuticals, Roche and Bristol-Myers Squibb. ....
Taysha Gene Therapies Expands Leadership Team to Deepen Manufacturing and Communications Capabilities itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Taysha Gene Therapies Expands Leadership Team to Deepen Manufacturing and Communications Capabilities - Press Release digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.